New research reveals early cardiometabolic risks associated with gestational diabetes

A US claims-based study uncovers that women with gestational diabetes face heightened risks of obesity, hypertension, and cardiovascular disease within just a few years of delivery, prompting calls for comprehensive postpartum monitoring.

A pregnancy complicated by gestational diabetes appears to signal a much broader health risk within only a few years of birth, not simply a later chance of developing diabetes. In a US claims-based study published online in JAMA Network Open on 12 August, researchers found that women with gestational diabetes faced sharply higher rates of type 2 diabetes and prediabetes after delivery, but also higher risks of obesity, hypertension, hyperlipidaemia, metabolic syndrome and, more modestly, cardiovascular disease. (jamanetwork.com)

The study drew on the Merative MarketScan commercial database and covered 1,153,998 commercially insured women in the United States aged 12 to 55 who had one recorded delivery between April 2007 and October 2023 and no known cardiovascular-kidney-metabolic disorder before giving birth. Of those, 95,103, or 8.2%, had gestational diabetes. Average age across the cohort was 28, while the women with gestational diabetes were older on average than those without it. Participants were followed from the day after delivery until a new diagnosis, loss of cover or the end of available data; median follow-up was 2.4 years, with a mean of 3.2 years. (jamanetwork.com)

The steepest excess risk was for abnormal glucose metabolism, which was expected but still striking in scale. After adjustment for age, calendar year, region, employment status and insurance type, gestational diabetes was associated with a tenfold higher hazard of type 2 diabetes and more than a fivefold higher hazard of prediabetes. The same pregnancy complication was also linked to a 2.72-fold higher risk of metabolic syndrome, a doubling of hyperlipidaemia risk, and roughly 75% higher risks of both hypertension and obesity. Crude incidence rates per 1,000 person-years were consistently higher in the gestational-diabetes group, including 9.9 versus 1.0 for type 2 diabetes and 19.9 versus 10.1 for hyperlipidaemia. (jamanetwork.com)

What gives the findings extra force is how early many of these problems were detected. In time-window analyses, the adjusted hazard ratio for type 2 diabetes was already 4.73 in the first year after birth, rose to 10.24 in years one to five, and remained elevated at 6.37 in years five to 10 and 4.39 beyond 10 years. Hyperlipidaemia, hypertension, obesity and metabolic syndrome also showed their clearest excess in the one-to-five-year period after delivery. Cardiovascular disease risk was smaller but still above baseline in years one to five and five to 10, while chronic kidney disease was not significantly associated in the main analysis. (jamanetwork.com)

That pattern supports a growing shift in how clinicians think about care after gestational diabetes. The JAMA Network Open paper places the findings within the cardiovascular-kidney-metabolic, or CKM, framework, which treats obesity, dysglycaemia, lipid disorders, kidney disease and cardiovascular disease as interlocking conditions rather than separate problems. The American College of Cardiology, in its summary of the paper, said the results argue for postpartum surveillance that extends beyond glucose testing to include blood pressure, lipids and weight. In other words, the weeks and months after birth may need to become a broader cardiometabolic check-in rather than a single test for persistent diabetes. (jamanetwork.com)

The work also sits inside a wider Stanford research programme looking at pregnancy as an early warning system for later illness. Stanford Medicine said lead author Larry Lili Liu, working with epidemiologist Michelle A. Williams, has used MarketScan data across a series of projects on pregnancy complications and long-term disease risk, including studies of metabolic dysfunction-associated steatotic liver disease, early-onset cancers and kidney outcomes after placental abruption. “The central idea behind much of our work is that pregnancy and reproductive conditions may serve as early signals for cardiometabolic, kidney, liver, and cancer outcomes later in life,” Liu said. (med.stanford.edu)

The study’s caveats are important. Because it relied on insurance claims, diagnoses were inferred from coding rather than direct clinical measurements, raising the possibility of misclassification. The dataset did not include pre-pregnancy body mass index, and the authors could not fully account for factors such as race, parity, smoking, socioeconomic status, previous hypertensive pregnancy disorders, medication use or patterns of healthcare use. The commercially insured cohort may also underrepresent women with less stable cover and a heavier burden of disease. That means the research shows association, not proof that gestational diabetes itself caused every later diagnosis. (jamanetwork.com)

There was also a note of uncertainty around kidney outcomes. The main analysis found no significant rise in chronic kidney disease risk, but a broader sensitivity definition that included proteinuria and hypertensive nephropathy did produce a positive association. Even so, the overall message is less about any single endpoint than about timing: the authors argue that the adverse trajectory is visible far earlier than many follow-up systems assume. For health services, that suggests gestational diabetes should be treated not as a complication resolved by delivery, but as a warning sign that longer-term prevention may need to start almost immediately after pregnancy ends. (jamanetwork.com)